[Medical treatment of pelvic inflammatory disease. A clinical study on the therapeutic effectiveness of piperacillin + erythromycin and of piperacillin + clindamycin + gentamycin].
The aim of the present clinical study was to evaluate the therapeutic effectiveness of two different antibiotic combinations (piperacillin + erythromycin and piperacillin + clindamycin + gentamycin) in the medical treatment of patients with pelvic inflammatory disease, respectively at the II and III stage. The findings confirm the therapeutic value and the low toxicity of both pharmacological regimens.
Sesti
F
F
II Università degli Studi di Roma, Clinica Ostetrica e Ginecologica.
Farnè
C
C
Piccione
E
E
D002981:Clindamycin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D010878:Piperacillin / Q000627:therapeutic use*; D012074:Remission Induction
D005839:Gentamicins; D002981:Clindamycin; D004917:Erythromycin; D010878:Piperacillin
Trattamento medico della malattia infiammatoria pelvica. Studio clinico sull'efficacia terapeutica di piperacillina + eritromicina e di piperacillina + clindamicina + gentamicina.